-
Light at the End of the Tunnel for ASPS PatientsImmunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
by Kyle Bagenstose
-
March 1: The Week in Cancer NewsMany women must make decisions about preserving fertility while dealing with a cancer diagnosis, and head and neck cancer survivors face a higher stroke risk.
by Kevin McLaughlin
-
CAR T-cell Therapy: Understanding the Warning and the RisksThe FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
-
February 23: The Week in Cancer NewsMelanoma drug becomes first cell therapy approved to treat a solid tumor, and a new method for treating mesothelioma extended patient survival in a recent trial.
by Thomas Celona
-
Overcoming Lung Cancer Stigma With UnderstandingShirley Muñoz wants to use her experience as a younger lung cancer patient to break down barriers to care for her community through translation and advocacy.
by Cameron Walker
-
The More You Know About Cancer PreventionStudies found awareness gaps about cancer prevention strategies such as screening and vaccination may reduce benefits from these tactics.
by Cancer Research Catalyst
-
February 16: The Week in Cancer NewsResearchers explore a try-everything approach to precision medicine, and physical activity may help ease cancer pain.
by Kevin McLaughlin
-
Using Acupuncture and Massage to Manage Side EffectsNew research finds acupuncture and massage are associated with pain reduction for patients with advanced cancer.
by Laura Gesualdi-Gilmore
-
February 9: The Week in Cancer NewsPatients and doctors urge researchers to study lower doses for cancer treatments, and the FDA faces criticism for not issuing a formaldehyde ban in hair straighteners.
by Marci A. Landsmann
-
February 2: The Week in Cancer NewsImproving fitness linked to lower prostate cancer risk, and a study from Scotland finds no cervical cancer cases in women vaccinated before age 14.
by Eric Fitzsimmons
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
